Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data

dc.contributor.authorGershman, Mark D.
dc.contributor.authorStaples, J.Erin
dc.contributor.authorBentsi-Enchill, Adwoa D.
dc.contributor.authorBreugelmans, J.Gabrielle
dc.contributor.authorBrito, Glacus S.
dc.contributor.authorBastos Camacho, Luiz A.
dc.contributor.authorCottin, Pascale
dc.contributor.authorDomingo, Cristina
dc.contributor.authorDurbin, Anna
dc.contributor.authorGascon, Joaquim
dc.contributor.authorGuenaneche, Fouzia
dc.contributor.authorHayes, Edward B.
dc.contributor.authorJelenik, Zsuzsanna
dc.contributor.authorKhromava, Alena
dc.contributor.authorMenezes Martins, Reinaldo de
dc.contributor.authorMasana Wilson, Mario
dc.contributor.authorMassy, Nathalie
dc.contributor.authorNasidi, Abdulsalami
dc.contributor.authorNiedrig, Matthias
dc.contributor.authorSherwat, Adam
dc.contributor.authorTsai, Theodore
dc.contributor.authorVilella i Morató, Anna
dc.contributor.authorWilson, Mary Elisabeth
dc.contributor.authorKohl, Katrin S.
dc.contributor.authorThe Brighton Collaboration Viscerotropic Disease Working Group
dc.date.accessioned2020-01-16T15:52:54Z
dc.date.available2020-01-16T15:52:54Z
dc.date.issued2012-07-13
dc.date.updated2020-01-16T15:52:54Z
dc.description.abstractViscerotropic disease (VTD) is defined as acute multiple organ system dysfunction that occurs following vaccination. The severity of VTD ranges from relatively mild multisystem disease to severe multiple organ system failure and death. The term VTD was first used shortly after the initial published reports in 2001 of febrile multiple organ system failure following yellow fever (YF) vaccination. To date, VTD has been reported only in association with YF vaccine and has been thus referred to as YF vaccine-associated viscerotropic disease (YEL-AVD).
dc.format.extent28 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec618829
dc.identifier.issn0264-410X
dc.identifier.pmid22561144
dc.identifier.urihttps://hdl.handle.net/2445/148049
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.vaccine.2012.04.067
dc.relation.ispartofVaccine, 2012, vol. 30, num. 33, p. 5038-5058
dc.relation.urihttps://doi.org/10.1016/j.vaccine.2012.04.067
dc.rights(c) Elsevier B.V., 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationVacunació
dc.subject.classificationEfectes secundaris dels medicaments
dc.subject.otherVaccination
dc.subject.otherDrug side effects
dc.titleViscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
618829.pdf
Mida:
1015.83 KB
Format:
Adobe Portable Document Format